About
NORDTREAT is a project between four Nordic countries and eight partners that are collaborating to develop an individualised treatment for people with inflammatory bowel disease (IBD). The goal is to improve the quality of life and outcome of this group. The project has been granted SEK 30 million from Nordforsk.
-
Summary
IBD is a disease entity of unknown origin, characterized by a chronic inflammation in the gastrointestinal tract. The disease course varies from an indolent course to an aggressive, treatment refractory disease, with need of repeated hospital admissions,...
-
Overarching aims
Improve treatment outcomes in IBD patients, by implementing a personalised medicine-based treatment strategy trial, built on a novel serum protein signature, and treating patients with a high risk of poor disease course according to a top-down algorithm...
-
Work Packages
1. Clinical Phenotyping (Lead: Dr. M.L Høivik, OUS, Norway) 2. Treatment Strategy study (Lead: Prof. J Halfvarson, ORU, Sweden) 3. Host and gut microbiome signatures (Lead: Prof. V. Andersen, SHS, Denmark) 4. Bioinfrmatics and intregrated analyses...
-
Profile
Title: The Nordic IBD treatment strategy trial Acronym: NORDTREAT Type: Research and Innovation Action Call: Innovations in Personalised Medicine: Towards implementation of personalised medicine in health care – Nordic PerMed Start: Sept 1,...